Expertise
Internationally recognized leaders in the field, PCCTC investigators come from the nation’s top academic medical centers where they are actively engaged in world class science through cutting-edge translational prostate cancer research.
The PCCTC was formed to address critically unmet needs in prostate cancer. Our mission is to design, implement, and complete process driven clinical trials, translating scientific discoveries to improved standards of care.
The PCCTC is changing how prostate cancer drugs are developed. Our unique infrastructure facilitates project co-development between investigators, clinical research sites and industry partners.
Internationally recognized leaders in the field, PCCTC investigators come from the nation’s top academic medical centers where they are actively engaged in world class science through cutting-edge translational prostate cancer research.
Principal Investigators Lorelei Mucci, ScD, MPH (Harvard T.H. Chan School of Public Health...
Learn MoreNew technology provides a major step forward in diagnosing and treating prostate cancer.
Learn MoreA new manuscript published in JCO Global Oncology describes the PCCTC managed IRONMAN Regi...
Learn MoreMore than 40,000 oncology professionals from around the world will convene at the annual A...
Learn MoreNORTH BILLERICA, MA, January 27, 2022 – Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus...
Learn MoreJoin our team of dedicated clinical research professionals! The Prostate Cancer Clinical Trials Consortium is currently seeking a Quality Manager and Clinical Data Manager to help fulfill our…
Our services translate scientific discoveries into improved standards of care, ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.